london euretina
retina race

Vitreomacular interface pathology incidence in a Spanish tertiary referral hospital

Session Details

Session Title: Imaging III

Session Date/Time: Saturday 19/09/2015 | 16:30-18:00

Paper Time: 16:30

Venue: Athena.

First Author: : M.Vidal Marti SPAIN

Co Author(s): :    I. FloresMoreno   A. Munoz-Blanco   L. AriasBarquet   M. RubioCaso   J. CaminalMitjana   J. RuizMoreno

Abstract Details

PURPOSE:To describe the incidence of vitreomacular interface pathology in a cohort of patients visited in a tertiary hospital.

Setting:

Bellvitge University Hospital, Barcelona (Spain)

Methods:

Retrospective, observational, single-center study. Retina first visit patients from November 2013 to October 2014 were reviewed. Patients were classified into the new vitreomacular interface pathology classification in 1) Macular posterior vitreous detachment (MPVD), 2) Vitreomacular adhesion (VMA): focal (<1500 μm) or broad (>1500 μm), 3) Vitreomacular traction (VMT): focal (<1500 μm) or broad (>1500 μm), 4) Full-thickness macular hole (FTMH): small (<250 μm), medium (> 250-≤400 μm) or large (>400 μm), status of vitreous: with or without VMT and the cause: primary or secondary to other diseases.

Results:

2412 eyes from 1221 patients were reviewed. 2018 eyes (83.6%) were imaged with spectral-domain optical coherence tomography (SD-OCT). 1047 eyes (51.8%) were included in the MPVD group, 116 (5,7%) in focal VMA, 702 (34,7%) in broad VMA, 33 (1.6%) in focal VMT, 29 (1,4%) in broad VMT, 39 (1,9%) were FTMH, including 5 small, 14 medium and 20 large FTMH. VMT associated to FTMH was found in 6 eyes, 38 were primary holes and 1 traumatic. 35 (1.7%) were not valuables due to a low quality in SD-OCT and 17 (0.8%) were not valuables due to previous pars plana vitrectomy.

Conclusions:

In a Spanish tertiary referral hospital, mostly of the patients studied were normal at the vitreomacular interface. In the pathologic group, 39 eyes were suitable for ocriplasmin treatment, although the rest should be better treat with a surgery procedure.

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy